Quick Answer

Can someone living with HIV have HIV-negative children?

Answered in plain language, anchored to primary sources.

Educational information only — not medical advice. Talk to your healthcare provider about your specific situation.
← Home
Share Facebook X WhatsApp Text Email LinkedIn Reddit Threads Bluesky

Yes. With antiretroviral therapy during pregnancy, appropriate delivery planning, and infant antiretroviral care, perinatal HIV transmission in the United States and Europe has fallen to 1% or less. A parent with a sustained undetectable viral load will also not transmit HIV to a partner during conception. Most people living with HIV who want children can have HIV-negative children.

The number that answers the question

The federal perinatal HIV guidelines state that current recommendations — universal prenatal HIV counseling and testing, antiretroviral therapy for all pregnancies with HIV, scheduled cesarean delivery when plasma HIV RNA exceeds 1,000 copies/mL near delivery, appropriate infant antiretroviral management, and infant feeding counseling — have resulted in a dramatic decrease in the rate of perinatal transmission of HIV to 1% or less in the United States and Europe.[1]

CDC's stated goal goes further: eliminating perinatal HIV transmission in the United States, defined as reducing it to fewer than 1 infection per 100,000 live births and a rate under 1% among infants exposed to HIV.[1]

None of this depends on unusual access or heroic effort. It depends on being on treatment, staying on treatment, and being connected to prenatal care — the same things that make anyone's pregnancy go well.

Getting pregnant safely

For a mixed-status couple trying to conceive, U=U does the work. CDC states that studies have shown no risk of sexual transmission from people who get and keep an undetectable viral load, with viral suppression defined as fewer than 200 copies per milliliter.[2]

PrEP is an additional option, not a replacement. CDC notes PrEP may be an option to help protect pregnant women and their babies from getting HIV while trying to get pregnant, during pregnancy, or while breastfeeding.[3] The perinatal guidelines have added dedicated guidance on PrEP use during periconception, pregnancy, and postpartum periods.[1]

If the partner living with HIV is not yet suppressed, the answer is usually timing rather than abandoning the plan. Federal guidelines recommend starting treatment immediately after diagnosis, and most people reach an undetectable viral load within six months.[4]

During pregnancy and delivery

Treatment continues throughout. Antiretroviral therapy is recommended for all pregnancies with HIV, and the goal is a consistently undetectable viral load through pregnancy and the postnatal period.[1]

Delivery mode is decided on viral load, not diagnosis. Scheduled cesarean delivery is recommended when plasma HIV RNA is above 1,000 copies/mL near delivery — which means most people with suppressed virus can plan a vaginal birth.[1]

Infants receive their own antiretroviral care. The guidelines now recommend performing a birth HIV nucleic acid test in nearly all scenarios, and three-drug presumptive treatment for infants at high risk of HIV acquisition consists of zidovudine/lamivudine plus either nevirapine or dolutegravir.[5]

Infant feeding is now a real conversation

This is where guidance has changed most in recent years. If antiretroviral therapy is taken consistently and viral load is maintained under 50 copies/mL — undetectable — for at least three months before delivery, the guideline panels recommend counseling about the options of formula feeding, banked donor milk, or breastfeeding.[5]

The residual risk is small but not zero. In the setting of parental treatment achieving consistently undetectable viral load throughout pregnancy and the postnatal period, along with appropriate neonatal antiretroviral prophylaxis, the risk of postnatal transmission through breast milk may be up to 1%.[1]

The panel also notes there is no evidence that formula supplementation increases the risk of HIV acquisition in a breastfed infant in the context of parental treatment and viral suppression, and gives specific guidance for mastitis.[5]

Florida angle: prenatal care and program support

In Florida, the practical path runs through Ryan White Part B, which provides services through 14 lead agencies to eligible clients in all counties of the state, filling gaps in care not covered by other resources.[6] Medications are covered through Florida's AIDS Drug Assistance Program for people who are uninsured or lack adequate prescription coverage, with income eligibility up to 400% of the federal poverty level.[7] Florida's Test and Treat guidance also directs county programs to start treatment within 24 hours of a new diagnosis[8] — which matters during pregnancy, when time to suppression is directly tied to outcomes.

Related questions

Will my baby need HIV medication?

Usually yes, for a short course, and a birth HIV nucleic acid test is now recommended in nearly all scenarios. Infants at higher risk receive a three-drug presumptive regimen. This is standard preventive care, not a sign anything went wrong, and your pediatric team will explain the schedule before delivery.

Can I breastfeed if I am undetectable?

It can now be a genuine option to discuss. When treatment is consistent and viral load has stayed under 50 copies per milliliter for at least three months before delivery, guidelines support counseling on formula feeding, banked donor milk, or breastfeeding. There is still a residual breast-milk transmission risk of up to about 1%.

Will I need a cesarean?

Not necessarily. Scheduled cesarean delivery is recommended specifically when viral load is above 1,000 copies per milliliter near delivery. If you are suppressed, delivery planning follows the same obstetric considerations as anyone else's pregnancy.

Can my HIV-negative partner get pregnant safely?

Yes. If the partner living with HIV has a sustained undetectable viral load, there is no risk of sexual transmission during conception. Some couples add PrEP for extra reassurance, which guidelines address for the periconception, pregnancy, and postpartum periods. Talk to a provider who handles both HIV and fertility care.

Last reviewed: August 30, 2026 by the RiseUpToHIV. Educational content only — not medical advice.

References & Sources

  1. NIH DHHS Perinatal Guidelines — Introduction. States perinatal transmission has fallen to 1% or less in the US and Europe, describes CDC's elimination goal, cesarean threshold above 1,000 copies/mL, PrEP guidance, and up to 1% breast-milk risk with suppression..
  2. CDC — HIV Treatment as Prevention. Defines viral suppression as under 200 copies/mL and states studies have shown no risk of sexual transmission with an undetectable viral load..
  3. CDC — Preventing HIV with PrEP. States PrEP may be an option to help protect pregnant women and their babies while trying to conceive, during pregnancy, or while breastfeeding..
  4. HIV.gov — Viral Suppression and an Undetectable Viral Load. States almost everyone taking HIV medicine as prescribed reaches an undetectable viral load, usually within six months..
  5. NIH DHHS Perinatal Guidelines — What's New. Describes infant feeding counseling when viral load is under 50 copies/mL for at least three months before delivery, birth HIV nucleic acid testing, three-drug infant presumptive treatment, and formula supplementation and mastitis guidance..
  6. Florida Department of Health — HIV Patient Care. States the Florida Ryan White Part B Program serves eligible clients in all counties through 14 lead agencies..
  7. Florida Department of Health — AIDS Drug Assistance Program. Sets ADAP eligibility at up to 400% of the federal poverty level for uninsured or inadequately covered people living with HIV..
  8. Florida Department of Health — HIV Test and Treat Guidance. Sets the state goal of starting antiretroviral therapy within 24 hours of diagnosis..

Community publications like POZ, Positively Aware, and TheBody inform framing and lived-experience context on RiseUpToHIV. Every clinical, epidemiological, or public-health claim above is anchored to a primary source.